Invesco Ltd. raised its position in shares of UiPath Inc. (NYSE:PATH - Free Report) by 10.5% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 382,800 shares of the company's stock after purchasing an additional 36,332 shares during the quarter. Invesco Ltd. owned 0.07% of UiPath worth $4,865,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also modified their holdings of the company. Norges Bank purchased a new position in shares of UiPath in the 4th quarter worth $71,191,000. Trexquant Investment LP purchased a new stake in shares of UiPath during the 4th quarter valued at about $15,611,000. Federated Hermes Inc. lifted its stake in shares of UiPath by 371.6% in the 4th quarter. Federated Hermes Inc. now owns 987,384 shares of the company's stock worth $12,550,000 after purchasing an additional 778,032 shares during the period. Vanguard Group Inc. boosted its holdings in shares of UiPath by 1.3% in the fourth quarter. Vanguard Group Inc. now owns 46,664,124 shares of the company's stock worth $593,101,000 after buying an additional 576,458 shares during the last quarter. Finally, Russell Investments Group Ltd. grew its position in UiPath by 73.8% during the fourth quarter. Russell Investments Group Ltd. now owns 1,118,774 shares of the company's stock valued at $14,220,000 after buying an additional 475,133 shares during the period. Institutional investors own 62.50% of the company's stock.
UiPath Stock Up 1.8 %
UiPath stock traded up $0.21 during mid-day trading on Tuesday, reaching $11.81. 8,675,118 shares of the company's stock traded hands, compared to its average volume of 10,638,135. UiPath Inc. has a 12-month low of $9.38 and a 12-month high of $20.95. The stock has a 50 day moving average of $11.21 and a two-hundred day moving average of $12.74. The company has a market cap of $6.51 billion, a price-to-earnings ratio of -73.81 and a beta of 1.04.
Insider Buying and Selling at UiPath
In other news, CAO Hitesh Ramani sold 12,500 shares of the firm's stock in a transaction dated Thursday, April 3rd. The shares were sold at an average price of $10.19, for a total value of $127,375.00. Following the completion of the sale, the chief accounting officer now owns 314,891 shares in the company, valued at approximately $3,208,739.29. This trade represents a 3.82 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 22.37% of the company's stock.
Analyst Upgrades and Downgrades
Several research analysts have weighed in on PATH shares. Barclays decreased their price target on shares of UiPath from $15.00 to $12.00 and set an "equal weight" rating on the stock in a research report on Thursday, March 13th. Wells Fargo & Company lowered their target price on UiPath from $13.00 to $11.00 and set an "equal weight" rating on the stock in a research report on Thursday, March 13th. UBS Group reduced their price target on UiPath from $14.00 to $10.00 and set a "sell" rating for the company in a research report on Thursday, March 13th. Morgan Stanley lowered their price objective on UiPath from $16.00 to $12.00 and set an "equal weight" rating on the stock in a research report on Thursday, March 13th. Finally, Evercore ISI reduced their target price on shares of UiPath from $16.00 to $12.00 and set an "in-line" rating for the company in a report on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Hold" and an average target price of $12.72.
View Our Latest Analysis on UiPath
UiPath Company Profile
(
Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Read More

Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.